Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-01-21 11:35 am Purchase | 13G | XENETIC BIOSCIENCES INC PA XBIO | Empery Asset Management LP | 137,419 2.33% | 137,419 (New Position) | View |
| 2020-01-21 11:32 am Purchase | 13G | TARONIS TECHNOLOGIES INC TRNX | Empery Asset Management LP | 3,093,359 4.99% | 3,093,359 (New Position) | View |
| 2020-01-21 11:30 am Sale | 13G | ADIAL PHARMACEUTICALS INC ADIL | Empery Asset Management LP | 791,250 4.99% | -163,750 (-17.15%) | View |
| 2020-01-21 11:27 am Unchanged | 13G | Trillium Therapeutics Inc. TRIL | Empery Asset Management LP | 5,300,000 4.99% | 0 (Unchanged) | View |
| 2020-01-15 10:10 am Unchanged | 13G | ENER CORE INC ENCR | Empery Asset Management LP | 9,285,933 4.99% | 0 (Unchanged) | View |
| 2020-01-15 10:09 am Sale | 13G | PULMATRIX INC PULM | Empery Asset Management LP | 5,583,644 4.99% | -1,799,999 (-24.38%) | View |
| 2020-01-15 10:08 am Sale | 13G | BIO-PATH HLDGS INC PAR $0. BPTH | Empery Asset Management LP | 5,148 0.14% | -157,852 (-96.84%) | View |
| 2020-01-15 10:06 am Sale | 13G | KITOV PHARMA LTD SPONSORED ADR KTOV | Empery Asset Management LP | 1,563,971 4.99% | -167,315 (-9.66%) | View |
| 2020-01-15 10:05 am Purchase | 13G | BIOPHARMX CORP COM BPMX | Empery Asset Management LP | 2,464,158 4.99% | 2,464,158 (New Position) | View |
| 2020-01-15 10:03 am Sale | 13G | IMMURON LTD SPONSORED ADR IMRN | Empery Asset Management LP | 9,554,767 4.99% | -417,041 (-4.18%) | View |
| 2020-01-15 10:01 am Purchase | 13G | BIOCEPT INC BIOC | Empery Asset Management LP | 2,309,027 4.99% | 1,979,027 (+599.71%) | View |
| 2020-01-15 10:01 am Sale | 13G | STAFFING 360 SOLUTIONS STAF | Empery Asset Management LP | 0 0% | -750,000 (Position Closed) | View |
| 2020-01-10 1:51 pm Purchase | 13G | CELLECT BIOTECHNOLOGY LTD SPON APOP | Empery Asset Management LP | 32,300,000 9.97% | 32,300,000 (New Position) | View |
| 2019-12-19 12:07 pm Purchase | 13G | AETHLON MED INC PAR $0.001 AEMD | Empery Asset Management LP | 787,545 9.99% | 787,545 (New Position) | View |
| 2019-11-27 4:10 pm Unchanged | 13G | 22ND CENTURY GROUP, INC XXII | Empery Asset Management LP | 10,543,211 7.69% | 0 (Unchanged) | View |
| 2019-11-21 12:18 pm Purchase | 13G | YIELD10 BIOSCIENCE INC YTEN | Empery Asset Management LP | 10,277,777 9.1% | 10,277,777 (New Position) | View |
| 2019-11-15 12:32 pm Purchase | 13G | APPLIED DNA SCIENCES INC P APDN | Empery Asset Management LP | 855,353 7.17% | 855,353 (New Position) | View |
| 2019-11-04 2:47 pm Purchase | 13G | GUARDION HEALTH SCIENCES INC C GHSI | Empery Asset Management LP | 7,200,000 9.82% | 7,200,000 (New Position) | View |
| 2019-10-22 09:55 am Purchase | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | Empery Asset Management LP | 3,333,333 6.32% | 3,333,333 (New Position) | View |
| 2019-10-07 1:33 pm Purchase | 13G | BENITEC BIOPHARMA LT BNTC | Empery Asset Management LP | 32,128,660 9.99% | 32,128,660 (New Position) | View |